Title : Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.

Pub. Date : 2022 Jan 6

PMID : 34991643






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Exogenous administration of nafamostat suppressed the hepatic inflammatory response, significantly reducing TNF and IFN-gamma expression, but had no effect on lung or brain cytokine production. nafamostat tumor necrosis factor Mus musculus